Temozolomide chemotherapy versus radiotherapy in high-risk low-grade glioma (EORTC 22033-26033): a randomised, open-label, phase 3 intergroup study
scientific article published on 26 September 2016
Author/s
author: Andreas von Deimling, Sebastian Kurscheid, Monika E Hegi, Olivier Chinot, Wolfgang Wick, David Capper, Jaap C Reijneveld, Alba A. Brandes, Thierry Gorlia, Roger Stupp, Jacoline C Bromberg, Martin J van den Bent, Brigitta G Baumert
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.